Symrise Ag

Barbara Rohm

Jakob Peter Ley

Gerhard Krammer

Sabine Widder

Veronika Somoza

Kathrin Liszt

Mark Somoza

Marc Pignitter

Christina Hochkogler

Matthias Zaunschirm

Mathias Zaunschirm

The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood. 

Hydroxyflavanones as appetite stimulants

Suggested are new compositions for oral ingestion, comprising at least one active agent from the group of alkamides. The compositions which are orally ingested reduce the uptake of free fatty acids in the adipocytes and at the same time stimulate the release of serotonin and dopamine, which leads to a reduction of appetite, a feeling of satiety and a positive mood. In doing so, the new compositions are thus perfectly suitable to counteract any undesired gain of weight.

Oral compositions

Growing community of inventors

Vienna, Austria

Barbara Rohm